This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Hiroshi Kurosu: Innovator in Glucose Transport Modulation
Introduction
Hiroshi Kurosu is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of glucose transport modulation through his innovative research and patents. His work focuses on the interaction between βKlotho and glucose transporter-1 (GLUT-1), which has implications for metabolic health.
Latest Patents
Hiroshi Kurosu holds a patent titled "FGF21 upregulates expression of GLUT-1 in a βKlotho-dependent manner." This patent describes a method to identify a modulator of βKlotho-dependent GLUT-1 upregulation that specifically influences the interaction between βKlotho and an FGFR. This research is crucial for understanding glucose metabolism and potential therapeutic applications.
Career Highlights
Hiroshi is affiliated with the University of Texas System, where he conducts his research. His work has garnered attention for its potential to impact treatments for metabolic disorders. With a focus on innovative solutions, he continues to explore the complexities of glucose transport mechanisms.
Collaborations
Hiroshi collaborates with esteemed colleagues, including Kevin P. Rosenblatt and Makoto Kuro-o. These partnerships enhance the depth and breadth of his research, contributing to advancements in the field.
Conclusion
Hiroshi Kurosu is a pioneering inventor whose work on GLUT-1 modulation has the potential to influence metabolic health significantly. His contributions to science and innovation are noteworthy and continue to inspire future research in glucose transport.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile